• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Why are BI oncology reps paid more than the rest of the company?













Really who cares. I always love these people who post on an anonymous board but in real life are insignificant.
You sound like Rob Rosenstein addressing a congressional committee hearing or speaking against everyday Americans.....arrogant as hell. Everyone else is “insignificant”. How dare we question or criticize tou. That’s the problem with the leaders of our country and corporate America. Feet should be held to the fire. Enough is enough.
 




People!! I cannot underemphasize how much you need to get out of this “organization”. The windbags that lead us are rudiculed in the industry. I could not believe my ears, and how much sense was made by people that either knew, or worked for BI leadership in the past. CF is a total ass and he may even tell you that himself. Rude and embarrassing according to some KOLs. DS is just his puppet and lives in his shadow until his big day arrives.

Free thinking lives and thrives outside of BI. You owe it to yourself to explore it. Not to mention... the pay and equity is a different league too. BI blows!!
 




















Rest assured- Oncology - the big swinging dick of BI is untouched. May have had some leadership changes earlier this year though.
Don’t let the therapeutic script begging sample droppers start to gossip
It’s all good up in here
 




















GSK is hiring a new oncology division. I wonder how many will go back there since this place is dying. Base salaries of the Tesaro reps they just acquired are in the 180s with a 50k Target IC
 








More people leaving. What is upper mgmt going to do about retention?


The oncology salaries are unsustainable. It's the same exact job as PC but different disease and reimbursement. Many people are calling for pharma to lower prices. If margins are cut the field is expendable...
especially at these inflated salaries.
 












considsr yourself lucky. Cardiology is safer than Oncology. We just had a downsizing and more is expected. Only one zone director, and he looks like he is on meth. Everyone is looking.